Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 34,098 followers.

@Noboru_Hagino @TT58852391 @takkman_rheum 個人的には、iguが試金石としては費用対効果がよいのでは？なんて思ってたりします。中国からの報告ばかりなので自分の施設でもいずれ試験してみたいですね！症例ベースではRA+SpA要素みたいな方に結構きくなと https://t.co/ztxd4NjA5B

29 Apr 2023

Reply Repost Favourite

New Research: Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials: Objective To explore the efficacy and safety of Iguratimod (IGU) intervention… https://t.co/

05 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.